Skip to content

Diabetes Coaching Program for Medicare Advantage Members With Type 2 Diabetes - Impact on A1c

Diabetes Coaching Program for Medicare Advantage Members With Type 2 Diabetes - Impact on A1c

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03363100
Enrollment
624
Registered
2017-12-06
Start date
2017-12-05
Completion date
2019-02-23
Last updated
2019-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Brief summary

The Diabetes Coaching Program for Medicare Advantage Members with Type 2 Diabetes - Impact on A1c trial is a 26-week long, prospective, intent-to-treat, 2-arm randomized controlled trial that aims to evaluate the impact of the Digital Health Partnership on A1c levels for individuals with uncontrolled Type 2 diabetes.

Interventions

BEHAVIORALDigital health Partnership program

The program pairs patients with their own certified diabetes educator coach who will guide the patient through a personalized program that leverages a proven educational curriculum combined with proven patient engagement methods.

Sponsors

Humana Co.Ltd.
CollaboratorINDUSTRY
Evidation Health
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Humana Medicare Advantage member * Type 2 diabetes diagnosis * HbA1c levels ≥ 8.0% verified by lab test

Exclusion criteria

* Has any of the following conditions: cancer, chronic heart failure, chronic obstructive pulmonary disease, respiratory failure, chronic kidney disease, end stage renal disease, peripheral vascular disease * Not fluent in English * Humana membership is part of a Full or Global risk arrangement * Enrolled in Humana at Home Care Management

Design outcomes

Primary

MeasureTime frameDescription
A1cBaseline and 6 monthsChange in A1c from study baseline to study end for participants

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026